iTeos Therapeutics, Inc.
ITOSDelisted Aug 29, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001808865
iTeos Therapeutics, Inc. was delisted on Aug 29, 2025; its insiders filed their last Form 4 on Aug 29, 2025; 137 institutions reported holding it in 13F filings for Q2 2025, worth $377.0M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in iTeos Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 146
- +4 vs. Q3 2022
- Shares held
- 36.2M
- −448.2K (−1.2%) vs. Q3 2022
- Total value
- $707.3M
- +$9.12M (+1.3%) vs. Q3 2022
- New holders
- 19
- 52 more added
- Sold out
- 15
- 45 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ITOS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $2.35K |
| Q2 2025 | 137 | $377.0M |
| Q1 2025 | 132 | $220.7M |
| Q4 2024 | 137 | $262.2M |
| Q3 2024 | 151 | $373.3M |
| Q2 2024 | 139 | $536.8M |
| Q1 2024 | 136 | $471.2M |
| Q4 2023 | 138 | $383.4M |
| Q3 2023 | 144 | $388.6M |
| Q2 2023 | 146 | $460.4M |
| Q1 2023 | 153 | $488.9M |
| Q4 2022 | 146 | $707.3M |
| Q3 2022 | 143 | $698.2M |
| Q2 2022 | 153 | $768.1M |
| Q1 2022 | 159 | $1.17B |
| Q4 2021 | 118 | $1.55B |
| Q3 2021 | 77 | $841.3M |
| Q2 2021 | 83 | $755.8M |
| Q1 2021 | 81 | $1.03B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding iTeos Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 90,865 | $1.77M | 0.00% | +23,027+33.9% | Added |
| DAFNA Capital Management LLC | 98,560 | $1.92M | 0.54% | +1,000+1.0% | Added |
| Rafferty Asset Management, LLC | 102,666 | $2.01M | 0.02% | −23,435−18.6% | Reduced |
| Allspring Global Investments Holdings, LLC | 108,670 | $2.12M | 0.00% | +39,569+57.3% | Added |
| Ameriprise Financial Inc | 121,987 | $2.38M | 0.00% | −176,346−59.1% | Reduced |
| Massachusetts Financial Services Co | 123,862 | $2.42M | 0.00% | +2,622+2.2% | Added |
| Prudential Financial Inc | 146,061 | $2.85M | 0.00% | +1,200+0.8% | Added |
| 683 Capital Management, LLC | 150,000 | $2.93M | 0.26% | +150,000 | New |
| Baker Bros. Advisors LP | 150,346 | $2.94M | 0.02% | 00.0% | Unchanged |
| Wellington Management Group LLP | 150,547 | $2.94M | 0.00% | +28,134+23.0% | Added |
| Principal Financial Group Inc | 158,488 | $3.10M | 0.00% | −10,661−6.3% | Reduced |
| Dimensional Fund Advisors LP | 165,151 | $3.23M | 0.00% | +147,277+824.0% | Added |
| American Century Companies Inc | 172,706 | $3.37M | 0.00% | −49,766−22.4% | Reduced |
| Charles Schwab Investment Management Inc | 182,489 | $3.56M | 0.00% | +4,322+2.4% | Added |
| AQR Capital Management LLC | 202,343 | $3.95M | 0.01% | −158,538−43.9% | Reduced |
| Tang Capital Management LLC | 216,700 | $4.23M | 0.61% | −720,800−76.9% | Reduced |
| AXA S.A. | 219,096 | $4.28M | 0.02% | −1,186−0.5% | Reduced |
| Citigroup Inc | 234,296 | $4.58M | 0.01% | −59,957−20.4% | Reduced |
| Bridgeway Capital Management, LLC | 243,500 | $4.76M | 0.12% | 00.0% | Unchanged |
| Northern Trust Corp | 253,687 | $4.95M | 0.00% | +11,874+4.9% | Added |
| Barclays PLC | 254,961 | $4.98M | 0.00% | +33,118+14.9% | Added |
| Integral Health Asset Management, LLC | 270,000 | $5.27M | 1.19% | +75,000+38.5% | Added |
| Bank of New York Mellon Corp | 274,373 | $5.36M | 0.00% | +60,082+28.0% | Added |
| Renaissance Technologies LLC | 317,100 | $6.19M | 0.01% | −75,800−19.3% | Reduced |
| FMR LLC | 354,998 | $6.93M | 0.00% | −91,279−20.5% | Reduced |
| Saturn V Capital Management LLC | 342,071 | $7.03M | 5.83% | +342,071 | New |
| Artal Group S.A. | 400,000 | $7.81M | 0.45% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 426,511 | $8.33M | 0.00% | +82,910+24.1% | Added |
| Octagon Capital Advisors LP | 445,000 | $8.69M | 1.35% | +445,000 | New |
| Geode Capital Management, LLC | 471,508 | $9.21M | 0.00% | +24,627+5.5% | Added |
| Bank of America Corp | 472,515 | $9.23M | 0.00% | +126,495+36.6% | Added |
| Jacobs Levy Equity Management, Inc | 503,530 | $9.83M | 0.07% | +37,205+8.0% | Added |
| JPMorgan Chase & Co | 583,958 | $11.4M | 0.00% | +41,053+7.6% | Added |
| Invesco Ltd. | 608,600 | $11.9M | 0.00% | +63,421+11.6% | Added |
| Candriam Luxembourg S.C.A. | 739,517 | $14.4M | 0.10% | 00.0% | Unchanged |
| Morgan Stanley | 846,859 | $16.5M | 0.00% | +12,965+1.6% | Added |
| Millennium Management LLC | 874,480 | $17.1M | 0.02% | +136,124+18.4% | Added |
| Citadel Advisors LLC | 1,355,427 | $26.5M | 0.03% | +33,544+2.5% | Added |
| State Street Corp | 1,737,290 | $33.9M | 0.00% | −370,578−17.6% | Reduced |
| MPM Oncology Impact Management LP | 1,745,943 | $34.1M | 8.85% | 00.0% | Unchanged |
| BVF Inc | 1,810,835 | $35.4M | 1.49% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,819,030 | $35.5M | 0.00% | +67,930+3.9% | Added |
| Boxer Capital, LLC | 2,154,058 | $42.1M | 2.26% | 00.0% | Unchanged |
| MPM Asset Management LLC | 2,738,785 | $53.5M | 22.38% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 4,417,259 | $86.3M | 1.75% | 00.0% | Unchanged |
| BlackRock Inc. | 4,479,421 | $87.5M | 0.00% | +162,264+3.8% | Added |
| SEI Investments Co | 0 | $0 | 0.00% | −96,529−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −86,200−100.0% | Sold out |
| Schroder Investment Management Group | 0 | $0 | 0.00% | −66,609−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −57,500−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −47,064−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −29,242−100.0% | Sold out |
| NinePointTwo Capital | 0 | $0 | 0.00% | −15,773−100.0% | Sold out |
| Gotham Asset Management, LLC | 0 | $0 | 0.00% | −13,493−100.0% | Sold out |
| Mutual of America Capital Management LLC | 0 | $0 | 0.00% | −4,883−100.0% | Sold out |
| Robeco Institutional Asset Management B.V. | 0 | $0 | 0.00% | −3,014−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −2,280−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −32−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| First Horizon Advisors, Inc. | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Wipfli Financial Advisors LLC, | – | – | – | – | Not filed |